Workflow
Credit Acceptance Announces Third Quarter 2025 Results
Globenewswire· 2025-10-30 20:01
Southfield, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $108.2 million, or $9.43 per diluted share, for the three months ended September 30, 2025. Adjusted net income, a non-GAAP financial measure, for the three months ended September 30, 2025 was $117.9 million, or $10.28 per diluted share. The following table summarizes our financial results: (In ...
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call
Globenewswire· 2025-10-30 20:01
RICHMOND, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the company has scheduled the release of its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. The company will hold a conference call at 8:30 a.m. Eastern on Thursday, November 6, which will remain open to the public. During the conference call, the company will review its financial results and provide business updates. Par ...
Asure Announces Third Quarter 2025 Results
Globenewswire· 2025-10-30 20:01
Third Quarter 2025 Total Revenues Increased 24% to $36.3 million  Recurring Revenues Grew 11% from Prior Year AUSTIN, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management software solutions, today reported results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights* Revenue of $36.3 million, up 24%Recurring revenue of $31.8 million versus $28.6 millionNet loss of $5.4 million versus a net ...
Coveo Reports Second Quarter Fiscal 2026 Financial Results
Prnewswire· 2025-10-30 20:01
Accessibility StatementSkip Navigation SaaS Subscription Revenue of $35.9 million, exceeding guidance Core Coveo SaaS Subscription Revenue growth of 17% Commerce remains Coveo's fastest-growing use case, fueled by expanding SAP partnership Continued Generative AI momentum with ~2.5x year-over-year growth in customers and revenue Coveo reports in U.S. dollars and in accordance with International Financial Reporting Standards ("IFRS") MONTREAL and SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ - Coveo (TSX: CV ...
MAGYAR BANCORP, INC. ANNOUNCES FISCAL FOURTH QUARTER AND FISCAL YEAR END FINANCIAL RESULTS, DECLARES QUARTERLY DIVIDEND
Prnewswire· 2025-10-30 20:01
Accessibility StatementSkip Navigation NEW BRUNSWICK, N.J., Oct. 30, 2025 /PRNewswire/ -- Magyar Bancorp (NASDAQ: MGYR) (the "Company"), parent company of Magyar Bank, reported today the results of its operations for the three months and fiscal year ended September 30, 2025. The Company reported $2.5 million in net income for the three months ended September 30, 2025 compared with net income of $2.5 million for the three months ended September 30, 2024. The Company also reported net income of $9.8 million f ...
Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy
Globenewswire· 2025-10-30 20:01
CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it will host a virtual event on Wednesday, November 12, 2025, to discuss its liver disease franchise and strategy, with a focus on Wilson’s Disease. Prime Medicine remains on track to file an investigational new drug (IND) and/or clinical trial application (CTA) for PM577, its Prime Edi ...
Canadian National Railway (NYSE:CNI) Quarterly Earnings Preview
Financial Modeling Prep· 2025-10-30 20:00
Core Insights - Canadian National Railway (CNI) is a significant entity in the North American rail industry, providing freight transportation services across Canada and the United States, and is a competitor to Canadian Pacific Kansas City and Union Pacific [1] - CNI is expected to release its quarterly earnings on October 31, 2025, with analysts estimating an earnings per share (EPS) of $1.28 and projected revenue of approximately $4.15 billion [1][5] - Despite anticipated lower revenues, CNI is expected to report a year-over-year increase in earnings for the quarter ending September 2025, with the consensus estimate aligning with expectations [2] Financial Metrics - CNI has a price-to-earnings (P/E) ratio of approximately 18.04, indicating market valuation of its earnings [3] - The price-to-sales ratio stands at about 4.78, reflecting the company's market value relative to its sales [3] - The enterprise value to sales ratio is around 5.98, suggesting how the company's total value compares to its sales [3] - The enterprise value to operating cash flow ratio is approximately 15.34, indicating the company's valuation in relation to its cash flow from operations [4] - The earnings yield is about 5.54%, providing insight into the return on investment for shareholders [4] - The debt-to-equity ratio is approximately 0.96, showing the proportion of debt used to finance the company's assets relative to shareholders' equity [4] - The current ratio is around 0.82, indicating the company's ability to cover its short-term liabilities with its short-term assets [4]
SS&C Technologies: Integration Strength And Consistency Already Priced In
Seeking Alpha· 2025-10-30 20:00
SS&C Technologies Holdings, Inc. (NASDAQ: SSNC ) is doing as well as you can expect for a business that provides software and tech-enabled services for companies in the healthcare and finance industries. TheI’m Emmanuel Onwusah—a financial analyst, writer, and recovering engineer. I hold FMVA® and BIDA® certifications from the Corporate Finance Institute, and I spend most of my time creating pitch decks, building models, analyzing companies, and trying to make sense of where value meets narrative. My backgr ...
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025
Globenewswire· 2025-10-30 20:00
IND application filed for MP0712, the Company’s lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images from MP0712 compassionate care program to be presented at TRP in November; additional programs planned for 2026, including MP0726 targeting mesothelin. Updated data from Phase 1/2a trial of MP0533, a multispecific T cell engager for AML, to be presented at ASH in December Protocol approved for Phase 2 investigat ...
Reddit's Big Rally & Recent Pullback: Can Earnings Reenergize RDDT Bulls?
Youtube· 2025-10-30 20:00
Welcome back to Market on Close. Another stock in focus after the close today is Reddit. It will report its earnings for the third quarter.Estimates calling for adjusted EPS of 52 cents on revenue of $550 million. And the company has topped both revenue and earning estimates for six consecutive quarters. Shares are up more than 20% so far this year.And that means it's time for Options Corner. Of course, we are looking at Reddit today ahead of those earnings. Joining us in studio here, Rick Dat, our lead mar ...